Showing 761 - 780 results of 1,182 for search '"liver disease"', query time: 0.13s Refine Results
  1. 761

    Diagnostic Imaging of Canine Hepatobiliary Affections: A Review by Vijay Kumar, Adarsh Kumar, A. C. Varshney, S. P. Tyagi, M. S. Kanwar, S. K. Sharma

    Published 2012-01-01
    “…The aim of clinicopathological evaluation of hepatobiliary affections is to identify and characterize hepatic damage and dysfunction, identify possible primary causes of secondary liver disease, differentiate causes of icterus, evaluate potential anaesthetic risks, assess prognosis and response to xenobiotics, and monitor response to therapy. …”
    Get full text
    Article
  2. 762

    Western Diet Decreases Hepatic Drug Metabolism in Male LDLr−/−ApoB100/100 Mice by Markus Koponen, Jaana Rysä, Anna-Kaisa Ruotsalainen, Olli Kärkkäinen, Risto O. Juvonen

    Published 2023-01-01
    “…Consumption of a Western diet is an important risk factor for several chronic diseases including nonalcoholic fatty liver disease (NAFLD), but its effect on the xenobiotic metabolizing enzyme activities in the liver has been studied incompletely. …”
    Get full text
    Article
  3. 763

    Wilson’s Disease: Diagnosis of Wilson’s Disease in Ethiopian Young Sisters by Nebiyu Bekele, Frew Ewnetu, Tigest Hailu, Zerubabel Tegegne, Abilo Tadesse

    Published 2020-01-01
    “…Both siblings had visible ocular Kayser–Fleischer rings, low serum ceruloplasmin level and increased urinary copper content, ultrasound-evidenced cirrhotic liver disease, and axial T2-weighted MRI hyperintensities in basal ganglia, thalamus, and brainstem (midbrain and pons). …”
    Get full text
    Article
  4. 764
  5. 765

    Methimazole-Induced Cholestatic Jaundice: A Rare Case and Literature Review by Ahmed Mohamed Nefzi, Dhouha Cherif, Habiba Dabbebi, Haythem Yacoub, Hajer Hassine, Hela Kchir, Khadija Bellil, Nadia Maamouri

    Published 2025-02-01
    “…Concomitant causes of liver disease were ruled out. The treatment was discontinued, and a switch to corticosteroid therapy with a regimen of radioactive iodine sessions was initiated. …”
    Get full text
    Article
  6. 766

    Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators by Yin Chan, Stephanie Pranke, Farid Rashidi, Shravan Nosib, Lawrence Worobetz

    Published 2017-01-01
    “…Emerging evidence suggests that nonalcoholic fatty liver disease (NAFLD) is associated with coronary artery diseases and arrhythmias. …”
    Get full text
    Article
  7. 767

    Demographics, aetiology and outcome of paediatric acute liver failure in Singapore by Fang Kuan Chiou, Veena Logarajah, Christopher Wen Wei Ho, Lynette Suk-Hui Goh, Sivaramakrishnan Venkatesh Karthik, Marion Margaret Aw, Kong Boo Phua

    Published 2022-11-01
    “…PALF was defined by: absence of chronic liver disease; biochemical evidence of acute liver injury; and coagulopathy, non-correctible by vitamin K, defined as prothrombin time (PT) ≥20 seconds or international normalised ratio (INR) ≥2.0 regardless of hepatic encephalopathy (HE) or PT ≥15 seconds or INR ≥1.5 in the presence of HE. …”
    Get full text
    Article
  8. 768

    Peritoneal Tuberculosis in an Immunocompetent, Unknown Risk Patient by Yutaka Tomizawa, Emmanuelle B. Yecies, Fiona E. Craig, Adam Sohnen

    Published 2013-01-01
    “…Physical examination was notable for new onset ascites, but no superficial lymphadenopathy or stigmata of chronic liver disease was found. CT scan demonstrated enlarged mesenteric lymph nodes, and prominent retroperitoneal lymph nodes along with moderate ascites and omental infiltration. …”
    Get full text
    Article
  9. 769

    Plasma α-Glutathione S-Transferase Evaluation in Patients with Acute and Chronic Liver Injury by Jolanta Czuczejko, Celestyna Mila-Kierzenkowska, Karolina Szewczyk-Golec

    Published 2019-01-01
    “…We aimed to investigate the significance of α-GST evaluation in monitoring of liver injury in acute and chronic liver diseases. 20 healthy volunteers and 52 patients were included in the study. …”
    Get full text
    Article
  10. 770

    Partial Replacement with Menhaden Oil Improves Peripheral Neuropathy in High-Fat-Fed Low-Dose Streptozotocin Type 2 Diabetic Rat by Lawrence J. Coppey, Amey Holmes, Eric P. Davidson, Mark A. Yorek

    Published 2012-01-01
    “…Endpoints included analyses of glucose tolerance, fatty liver disease, serum and liver fatty acid composition, serum lipid and adiponectin levels, motor and sensory nerve conduction velocity, thermal sensitivity and innervation of the hindpaw. …”
    Get full text
    Article
  11. 771

    Virological Mechanisms in the Coinfection between HIV and HCV by Maria Carla Liberto, Emilia Zicca, Grazia Pavia, Angela Quirino, Nadia Marascio, Carlo Torti, Alfredo Focà

    Published 2015-01-01
    “…The immune-pathogenesis of liver disease in HIV/HCV coinfected patients is a multifactorial process. …”
    Get full text
    Article
  12. 772

    Update on a Pharmacokinetic-Centric Alternative Tier II Program for MMT—Part II: Physiologically Based Pharmacokinetic Modeling and Manganese Risk Assessment by Michael D. Taylor, Harvey J. Clewell, Melvin E. Andersen, Jeffry D. Schroeter, Miyoung Yoon, Athena M. Keene, David C. Dorman

    Published 2012-01-01
    “…We also present novel PBPK simulations to predict manganese tissue concentrations in fetal, neonatal, pregnant, or aged individuals, as well as individuals with liver disease or chronic manganese inhalation. The results of these simulations could help guide risk assessors in the application of uncertainty factors as they establish exposure guidelines for the general public or workers.…”
    Get full text
    Article
  13. 773

    Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters by Katherine J. P. Schwenger, Julia K. Copeland, Yasaman Ghorbani, Lina Chen, Elena M. Comelli, David S. Guttman, Sandra E. Fischer, Timothy D. Jackson, Allan Okrainec, Johane P. Allard

    Published 2025-01-01
    “…Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a range of histological findings from the generally benign simple steatosis to steatohepatitis (MASH) which can progress to fibrosis and cirrhosis. …”
    Get full text
    Article
  14. 774
  15. 775
  16. 776

    Feasibility and Safety of ERCP in the Treatment of Biliary Strictures after Liver Transplantation: With a Report of 37 Cases by Fanfan Tang, Jingtao Song, Tanxing Cai, Zhao Lei, Feizhou Huang, Yina Hu, Gang Deng

    Published 2022-01-01
    “…Liver transplantation (LT) is an effective treatment option for patients with end-stage liver disease; biliary complications are important cause of death in posttransplant patients. …”
    Get full text
    Article
  17. 777

    Hyperuricemia-induced complications: dysfunctional macrophages serve as a potential bridge by Wenyi Gu, Wenyi Gu, Jiajing Zhao, Yu Xu, Yu Xu, Yu Xu

    Published 2025-01-01
    “…Characterized by elevated levels of UA, HUA has become an independent risk factor for gout, chronic kidney disease, insulin resistance, cardiovascular disease, nonalcoholic fatty liver disease, etc. As HUA is a metabolic syndrome, the immune response is likely to play an active role throughout the whole process. …”
    Get full text
    Article
  18. 778

    Treatment compliance of liver cirrhosis patients by Ye. R. Olevskaya, A. I. Dolgushina, A. N. Tarasov, D. S. Mikhaylova, A. R. Molchanova, A. S. Kuznetsova

    Published 2018-08-01
    “…Development of LC was the outcome of viral hepatitis, alcoholic liver disease and other diseases in 13, 14 and 16 patients respectively. …”
    Get full text
    Article
  19. 779
  20. 780

    Acute Liver Failure among Patients on Efavirenz-Based Antiretroviral Therapy by Innocent Lule Segamwenge, Miriam Kaunanele Bernard

    Published 2018-01-01
    “…All these patients had been treated with a range of Efavirenz containing antiretroviral regimens and were negative for hepatitis A, B, and C infections as well as other opportunistic infections, all were negative for autoimmune hepatitis, and none had evidence of chronic liver disease or use of alcohol or herbal medications. …”
    Get full text
    Article